Andrew R. de Guttadauro

Andrew R. de Guttadauro

Presidente presso Oncolytics Biotech (U.S.), Inc.

Patrimonio netto: 11 037 $ in data 31/05/2024

57 anni
Health Technology
Consumer Services
Health Services

Provenienza dei contatti di primo grado di Andrew R. de Guttadauro

EntitàTipo di entitàSettore Industriale
2
Subsidiary Pharmaceuticals: Major 2
2
Extinct Pharmaceuticals: Major 2

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Andrew R. de Guttadauro tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
MERCK & CO., INC. Pharmaceuticals: Major

Ronald B. Moss

General Counsel

Medical Specialties

Richard Kenney

Chief Tech/Sci/R&D Officer

Financial Conglomerates

Ronald B. Moss

Chief Executive Officer

MARKER THERAPEUTICS, INC. Biotechnology

Richard Kenney

Chief Tech/Sci/R&D Officer

ONCOLYTICS BIOTECH INC. Biotechnology

Mary Ann Dillahunty

Kirk Look

Corporate Officer/Principal

Director of Finance/CFO

Biotechnology

Ronald B. Moss

Director/Board Member

Michigan State University College/University

Mary Ann Dillahunty

Undergraduate Degree

George Washington University College/University

Mary Ann Dillahunty

Richard Kenney

Masters Business Admin

Undergraduate Degree

Miscellaneous Commercial Services

Kirk Look

Corporate Officer/Principal

Stony Brook University College/University

Ronald B. Moss

Undergraduate Degree

University of Calgary College/University

Kirk Look

Undergraduate Degree

IOMAI CORPORATION Biotechnology

Richard Kenney

Chief Tech/Sci/R&D Officer

General Government

Ronald B. Moss

Corporate Officer/Principal

Pharmaceuticals: Major

Richard Kenney

Chief Tech/Sci/R&D Officer

General Government

Richard Kenney

Corporate Officer/Principal

Miscellaneous Commercial Services

Kirk Look

Corporate Officer/Principal

Rosalind Franklin University of Medicine & Science College/University

Ronald B. Moss

Doctorate Degree

American Federation for Medical Research

Richard Kenney

Corporate Officer/Principal

Miscellaneous Commercial Services

Richard Kenney

Corporate Officer/Principal

IMMUNE DESIGN CORP Pharmaceuticals: Major

Richard Kenney

Chief Tech/Sci/R&D Officer

Telos Pharmaceuticals LLC

Ronald B. Moss

Chief Tech/Sci/R&D Officer

Immunization Products Ltd.

Ronald B. Moss

Corporate Officer/Principal

DMK PHARMACEUTICALS CORPORATION Pharmaceuticals: Major

Ronald B. Moss

Chief Tech/Sci/R&D Officer

Harvard Medical School College/University

Richard Kenney

Doctorate Degree

Stanford Law School College/University

Mary Ann Dillahunty

Graduate Degree

Seton Hall University School of Law College/University

Kirk Look

Graduate Degree

Pharmaceuticals: Major

Ronald B. Moss

Chief Executive Officer

Biotechnology

Richard Kenney

Corporate Officer/Principal

ClinReg Biologics LLC

Richard Kenney

President

SONNET BIOTHERAPEUTICS HOLDINGS, INC. Biotechnology

Richard Kenney

Chief Tech/Sci/R&D Officer

Chicago Medical School College/University

Ronald B. Moss

Doctorate Degree

Statistiche

Distribuzione geografica

Stati Uniti 26
Canada 5
Cile 2
Paesi Bassi 2

Settori

Health Technology 13
Consumer Services 10
Commercial Services 4
Government 3
Finance 2

Posizioni

Chief Tech/Sci/R&D Officer 12
Corporate Officer/Principal 9
President 4
Undergraduate Degree 4
Doctorate Degree 3